These findings demonstrated that caspase-7 downregulation can at least partially account for SREBP1 overexpression in colon cancer, which provides important insights into the mechanisms underlying SREBP1 overexpression in chemoresistant CRC. The gene discussed is SREBF1; the disease is colonic neoplasm.